Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127426 trials found · Page 3461 of 6372
-
New study aims to predict chemo risks for seniors with breast cancer
Knowledge-focused OngoingThe goal of this study is to develop a "bedside to bench" model of clinical and biological predictors for toxicity to adjuvant and neoadjuvant chemotherapy in older adults with breast cancer. The investigators will develop a predictive model using clinical and biological predicto…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Scientists harvest cells to grow mini retinas in lab
Knowledge-focused Recruiting nowBackground: \- Best Vitelliform Dystrophy (Best disease), Late-Onset Retinal Degeneration (L-ORD), and Age-Related Macular Degeneration (AMD) all affect the retina, the light sensing area at the back of the eye. Doctors cannot safely obtain retinal cells to study these diseases.…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Synthetic bone patch could rebuild noses without extra surgery
Disease control CompletedThe aim of this project is to evaluate the safety and efficacy of the biomaterial made of HAP/TCP (BCP, Kasios®), in septoplasties of multi traumatized human nose. The use of this biomaterial will avoid the graft sampling and we expect it to be a good substitute to support the na…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Diabetes drug shows promise against deadly skin cancer in early trial
Disease control CompletedIn western countries, melanoma represents a major mistake of public health by its frequency, lethality and the increasing of incidence. Surgery can cure melanoma diagnosed very early. In other cases, it exists a risk of recurrence of lymph node and visceral. At the stage of visce…
Phase 2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Home workouts and light boxes tested for brain injury rehab
Symptom relief CompletedBackground: * Traumatic brain injury may have a range of effects, from severe and permanent disability to more subtle functional and cognitive deficits that often go undetected during initial treatment. To improve treatments and therapies and to provide a uniform quality of care…
Phase 1/2 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
New hope for acoustic neuroma: direct brain infusion of avastin in early trial
Disease control PausedA recent study by Plotkin et al. showed that bevacizumab (Avastin) treatment was followed by clinically meaningful hearing improvement, tumor-volume reduction, or both in some, but not all, patients with Vestibular Schwannoma (VS) who were at risk for complete hearing loss or bra…
Phase 1 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Vitamin d and exercise may fight bone loss in breast cancer survivors
Disease control OngoingThis research will examine the effectiveness of vitamin D or placebo (the placebo is a tablet that looks like Vitamin D study drug, but has no Vitamin D study drug in it), with and without physical activity (walking and progressive resistance exercise), in treating bone loss in w…
Phase 2 • Sponsor: University of Rochester • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New allergy pill shows promise for kids with constant stuffy nose
Symptom relief CompletedThe objectives of this study are: to confirm the superiority of TAU-284 over placebo after two weeks of administration to pediatric patients with perennial allergic rhinitis, and to investigate the dose response, safety, and plasma concentrations of TAU-284.
Phase 3 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Promising drug combo targets rare spine tumor
Disease control CompletedThe study drug, Nilotinib, is believed to slow down tumor growth by regulating a gene involved in cellular growth of chordoma cells. During this research study, subjects will also receive radiation therapy which is considered a standard treatment for advanced chordomas. It is hop…
Phase 1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New combo chemo regimen shows promise in early cancer trial
Disease control CompletedThe aim of the study is to determine the MTD of Paclitaxel in association with metronomic Cyclophosphamide.
Phase 1 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can removing certain immune cells make stem cell transplants safer for myeloma patients?
Disease control CompletedThe purpose of this study is to test whether regulatory T-cell reduction is possible and safe in myeloma subjects undergoing autologous stem cell transplantation (ASCT).
Phase 1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New study explores BRCA mutations in hispanic breast cancer patients
Knowledge-focused CompletedBackground: \- BRCA1 and BRCA2 gene mutations have been linked to a higher risk of developing breast cancer and other cancers, and may be associated with types of breast cancer that are more difficult to treat and more likely to recur. New cancer treatments are being developed s…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Light-Activated therapy shows promise for tumor control without surgery
Knowledge-focused OngoingFrom 1996-present, we have used photodynamic therapy (PDT) to treat a number of neoplastic diseases both on prospective research protocols (for head and neck cancer, pleural malignancies, peritoneal carcinomatosis or sarcomatosis and prostate cancer) as well as for FDA approved a…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Personalized vitamin d dosing may beat standard approach in breast cancer patients
Disease control CompletedThe purpose of this study is to compare normalization of vitamin D serum level after 6 months of vitamin D supplementation adjusted to baseline vitamin D serum level vs.conventional vitamin D supplementation.
Phase 3 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can cutting four foods ease Kids' esophagus inflammation?
Disease control OngoingThis study is to observe the efficacy of the four food elimination diet.
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Can a drug plus brain exercises boost recovery after stroke?
Symptom relief CompletedThe investigators would like to conduct a double blind placebo-controlled prospective study to show the impact of a treatment combining a specific cognitive rehabilitation program and acetylcholinesterase inhibitors on executive function of young patients 3 months after a first s…
Phase 2 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Robot vs. surgeon: which surgery is safer for pelvic organ prolapse?
Disease control CompletedThe primary objective of this study is to compare 30-day complication rates associated with promontofixation for pelvic organ prolapse performed via a robot-assisted laparoscopic technique versus a non-robot-assisted laparoscopic technique. Secondary objectives include comparing …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug combo targets tumors in patients with organ failure
Disease control OngoingThis phase I trial studies the side effects and the best dose of veliparib when given together with paclitaxel and carboplatin in treating patients with solid tumors that are metastatic or cannot be removed by surgery and liver or kidney dysfunction. Veliparib may stop the growth…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Brain training shows promise for bipolar thinking problems
Symptom relief CompletedThe purpose of the present study is to evaluate a neuroplasticity-oriented, computer-based cognitive remediation treatment program in patients with bipolar disorder and its effects on cognitive deficits and community functioning compared to an active, computer-based control.
Sponsor: Mclean Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Urine test may replace needle biopsy for kidney transplant patients
Knowledge-focused CompletedThe investigators have shown that epithelial-to-mesenchymal transition (EMT) markers in early protocol biopsies of the renal allograft predicts the progression of fibrosis during the first year post-transplantation. The investigators will develop a non-invasive approach for pred…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC